Health News Archive - May 03, 2010
Hartford Earns Top Bragging Rights; Pittsburgh Fails to Make the Grade SCHAUMBURG, Ill., May 3 /PRNewswire-USNewswire/ -- At first glance, Hartford, Salt Lake City and Denver might not seem to have much in common.
SCHAUMBURG, Ill., May 3 /PRNewswire-USNewswire/ --The American Academy of Dermatology's (Academy) "Suntelligence: How Sun Smart is Your City?" survey polled adults in 26 U.S.
PARSIPPANY, N.J., May 3 /PRNewswire/ -- DSM Biologics is pleased to announce the signing of preliminary agreements to enter a partnership with the Australian Governments (Queensland State Government and the Commonwealth of Australia) to design, build and operate the first major Australia-based mammalian biopharmaceutical manufacturing facility, which will be located in Brisbane. The over 70,000 square foot facility will offer mammalian process development and cGMP clinical and commercial manufacturing services.
LONDON, May 3 /PRNewswire/ -- Based on its recent research on the medical imaging market, Frost & Sullivan presents TeraRecon with the 2010 European Frost & Sullivan Award for Company of the Year. Innovation in technology is TeraRecon's Unique Selling Proposition (USP).
KINGWOOD, Texas, May 3 /PRNewswire-FirstCall/ -- John Flinn, the President of International Merchant Advisors, Inc. (Other OTC: IMAI) www.imaiinc.com subsidiary Organic Science, has been named Chief Executive Officer of International Merchant Advisors, Inc. (IMAI).
LEAGUE CITY, Texas, May 3 /PRNewswire/ -- For over 60 years, Standard Life and Accident Insurance Company has provided exceptional coverage for senior citizens.
SAN FRANCISCO, May 3 /PRNewswire/ -- SARcode Corporation, a privately-held biotechnology company focused on developing a novel class of lymphocyte function-associated antigen-1 (LFA-1) antagonists, today announced results of a 230 patient Phase 2 proof-of-concept study evaluating topical SAR 1118 ophthalmic solution in the treatment of aqueous deficient dry eye (keratoconjunctivitis sicca).
MISGAV, Israel, May 3, 2010 /PRNewswire/ -- PolyTouch Medical Ltd., a leading developer of laparoscopic hernia mesh placement technologies, today announced that it has filed a Premarket 510(k) Application with the US Food and Drug Administration for PatchAssist, an Innovative Laparoscopic Mesh Deployment and Placement Device that enables accurate mesh placement in laparoscopic ventral hernia repair potentially reducing procedure time by 30%-50%. PatchAssist is a standalone surgical mesh placement device that is compatible with all common hernia meshes and supports a wide span of mesh sizes including the largest mesh sizes in the market.
MISGAV, Israel, May 3, 2010 /PRNewswire/ -- - The Company is Developing an Artificial Sphincter (the AOS-C1000) to Provide Bowel Control and Prevent Clinical Complications for People With Stomas. Stimatix GI, located in the Misgav Venture Accelerator, has reported encouraging interim results in its animal trials of the AOS-C1000 artificial sphincter, designed to provide stoma patients with a new means of bowel control. The interim results demonstrate that the AOS-C1000 artificial sphincter can restore voluntary control to people with stoma. A stoma is the result of a surgical procedure that diverts the end of the bowel to an artificial opening ("stoma") in the abdominal wall.
MISSION VIEJO, Calif., May 3 /PRNewswire-FirstCall/ -- The Ensign Group, Inc.
- The governor of a province or people.